cis-2-Cyclopentyl-cyclopentylamin | 687996-16-3

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: cis-2-Cyclopentyl-cyclopentylamin
• 英文别名: (1S,2S)-bicyclopentyl-2-ylamine；(1S,2S)-2-cyclopentylcyclopentan-1-amine
• CAS: 687996-16-3
• 化学式: C₁₀H₁₉N
• 分子量: 153.268
• InChiKey: MYBGJAXNVXWOKZ-UWVGGRQHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  cis-2-Cyclopentyl-cyclopentylamin 在 盐酸 、 乙醚 作用下， 生成 cis-2-acetylamino-bicyclopentyl
  参考文献：
  名称：

  Hueckel; Gross; Doll, Recueil des Travaux Chimiques des Pays-Bas, 1938, vol. 57, p. 555,561

  摘要：

  DOI：
• 作为产物：
  描述：

  2-cyclopentyl-N-(1-phenylethyl)cyclopentan-1-amine 在 氢气 、 溶剂黄146 作用下， 以 甲醇 为溶剂， 反应 18.0h， 生成 cis-2-Cyclopentyl-cyclopentylamin
  参考文献：
  名称：

  The identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1-hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-acting β2-adrenoceptor agonist

  摘要：

  The optimisation of two series of 4-hydroxybenzothiazolone derived β2-adrenoceptor agonists, bearing α-substituted cyclopentyl and β-phenethyl amino-substituents, as inhaled long-acting bronchodilators is described. Analogues were selected for synthesis using a lipophilicity based hypothesis to achieve the targeted rapid onset of action in combination with a long duration of action. The profiling of the two series led to identification of the α-substituted cyclopentyl analogue 2 as the optimal compound with a comparable profile to the inhaled once-daily long-acting β2-adrenoceptor agonist indacaterol. On the basis of these data 2 was promoted as the backup development candidate to indacaterol from the Novartis LABA project.

  DOI：

  10.1016/j.bmcl.2014.06.014

文献信息

• [EN] BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY<br/>[FR] DERIVES DE BENZOTHIAZOLE AYANT UNE ACTIVITE D'AGONISTE DU BETA-2-ADRENORECEPTEUR
  申请人：NOVARTIS AG

  公开号：WO2004016601A1

  公开（公告）日：2004-02-26

  Compounds of Formula (I) in free or salt or solvate form, wherein X has the meaning indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the ß2-adrenoreceptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.

  公式(I)中的化合物以自由形式、盐或溶剂形式存在，其中X具有规范中指示的含义，可用于治疗通过激活β2-肾上腺素受体预防或缓解的症状。还描述了含有这些化合物的药物组合物以及制备这些化合物的方法。
• Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
  申请人：Cuenoud Bernard

  公开号：US20060106075A1

  公开（公告）日：2006-05-18

  Compounds of formula (I) in free or salt or solvate form, wherein X has the meaning indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the β 2 -adrenoreceptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.

  式(I)的化合物，包括自由形式、盐形式或溶剂合物形式，其中X的含义如规范中所示，可用于治疗通过激活β2-肾上腺素能受体预防或缓解的疾病。还描述了包含该化合物的制药组合物和制备该化合物的过程。
• ORGANIC COMPOUNDS
  申请人：CUENOUD Bernard

  公开号：US20150065490A1

  公开（公告）日：2015-03-05

  Compounds of formula I in free or salt or solvate form, wherein X has the meaning indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the β 2 -adrenoreceptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.

  公式I的化合物，无论是自由形式、盐形式或溶剂形式，其中X的意义在说明书中指示，可用于治疗通过激活β2-肾上腺素受体预防或缓解的疾病。还描述了含有这些化合物的制药组合物以及制备这些化合物的过程。
• Hueckel; Ude, Chemische Berichte, 1961, vol. 94, p. 1026,1032
  作者：Hueckel、Ude

  DOI：——

  日期：——
• BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY
  申请人：Novartis AG

  公开号：EP1529038A1

  公开（公告）日：2005-05-11